FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Vivos Gets Sleep Apnea Device Cleared

FDA clears a Vivos Therapeutics 510(k) for its daytime-nighttime appliance for treating obstructive sleep apnea and snoring in adults.

latest-news-card-1
Human Drugs

Consider Oncology Single-Arm Trial Issues: CDER

CDER researchers discuss some of the challenges in using single-arm trials to support the approval of oncology drugs.

latest-news-card-1
Human Drugs

FDA Lifts Partial Hold on Bluebird Bio Lovo-Cel Study

Bluebird Bio says it is working to resume enrollment and treatment of patients ages 2-17 in a lovo-cel sickle cell clinical trial after FDA lifts a pa...

latest-news-card-1

FTC Updates Health Products Compliance Guide

Attorney Phyllis Marcus says an updated Federal Trade Commission compliance guidance covers dietary supplements and adds many additional health-relate...

Human Drugs

CGMP Deviations Found at MD Pharmaceutical Supply

FDA warns Hanover, PA-based MD Pharmaceutical Supply about CGMP deviations in its drug repackaging and relabeling operations.

latest-news-card-1
Human Drugs

CGMP Deviations at Brazils Nortec Quimica

FDA warns Brazils Nortec Quimica about CGMP deviations in its production of active pharmaceutical ingredients.

latest-news-card-1
Human Drugs

FDA States Plan B One-Step Does Not Cause an Abortion

FDA revises the Plan B One-Step information sheet to clarify the emergency contraceptive cannot be used to cause an abortion of an existing pregnancy.

latest-news-card-1
Human Drugs

Court Enters Consent Decree Against Oklahoma Compounder

An Oklahoma federal court issues a consent decree against the Qualgen drug compounding facility and two of its principals.

latest-news-card-1
Medical Devices

Spending Bill Reverses Some FDA Court Losses: Attorneys

Two Hyman, Phelps & McNamara attorneys say FDA succeeded in having Congress use the recent omnibus spending bill to allow it to ban some individual us...

latest-news-card-1
Human Drugs

FDA Pushing Naloxone OTC Switch: Attorney

Attorney Heidi Gertner explains how FDA is pushing for a voluntary Rx to OTC switch of naloxone drug products.